Smith R P, Schmid G P, Baltch A L, Sutphen N T, Hammer M C
Am J Med Sci. 1981 Jan-Feb;281(1):19-24. doi: 10.1097/00000441-198101000-00003.
Concentration of cefaclor, a new oral cephalosporin, was measured in prostatic tissue of ten patients undergoing suprapubic prostatectomy. The average prostatic tissue concentrations were 0.51 +/- 0.22 microgram and 0.74 +/- 0.67 microgram per gram of tissue following the oral administration of 250-milligram and 500-milligram doses, respectively. The prostate/plasma ratios of cefaclor were approximately 0.7 indicating no evidence of accumulation of the drug in prostatic tissue. Levels of cefaclor achieved in human prostatic disease are equal to or less than the minimum inhibitory concentration of strains of known facultative bacterial pathogens associated with prostatitis.
对十名接受耻骨上前列腺切除术的患者的前列腺组织中新型口服头孢菌素头孢克洛的浓度进行了测定。口服250毫克和500毫克剂量后,每克组织的平均前列腺组织浓度分别为0.51±0.22微克和0.74±0.67微克。头孢克洛的前列腺/血浆比率约为0.7,表明该药物在前列腺组织中没有蓄积迹象。在人类前列腺疾病中达到的头孢克洛水平等于或低于与前列腺炎相关的已知兼性细菌病原体菌株的最低抑菌浓度。